INEB-Institute of Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.
i3S-Institute for Research & Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Nutrients. 2023 Feb 28;15(5):1223. doi: 10.3390/nu15051223.
Heart failure (HF) is a debilitating disease with a significant clinical and economic impact worldwide. Multiple factors seem to increase the risk of developing HF, such as hypertension, obesity and diabetes. Since chronic inflammation plays a significant role in HF pathophysiology and gut dysbiosis is associated with low-grade chronic inflammation, the risk of cardiovascular diseases is likely modulated by the gut microbiome (GM). Considerable progress has been made in HF management. However, there is a need to find new strategies to reduce mortality and increase the quality of life, mainly of HFpEF patients, since its prevalence continues to rise. Recent studies validate that lifestyle changes, such as diet modulation, represent a potential therapeutic approach to improve several cardiometabolic diseases, although their effects on the GM and its indirect cardiac impact still warrant further research. Hence, in this paper, we aim to clarify the link between HF and the human microbiome.
心力衰竭(HF)是一种具有重大临床和经济影响的衰弱性疾病。多种因素似乎会增加患 HF 的风险,例如高血压、肥胖症和糖尿病。由于慢性炎症在 HF 病理生理学中起着重要作用,而肠道菌群失调与低度慢性炎症有关,因此肠道微生物组(GM)可能会调节心血管疾病的风险。HF 的管理已经取得了相当大的进展。然而,需要寻找新的策略来降低死亡率并提高生活质量,主要是 HFpEF 患者的生活质量,因为其患病率仍在上升。最近的研究证实,生活方式的改变,如饮食调节,代表了改善几种心脏代谢疾病的潜在治疗方法,尽管其对 GM 及其对心脏的间接影响仍需要进一步研究。因此,在本文中,我们旨在阐明 HF 与人类微生物组之间的联系。